Literature DB >> 6101433

Response to thymopoietin pentapeptide in patient with DiGeorge syndrome.

F Aiuti, L Businco, P Rossi, I Quinti.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6101433     DOI： 10.1016/s0140-6736(80)90512-7

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  3 in total

1.  Selective defect of a T helper subpopulation in severe combined immunodeficiency.

Authors:  L Businco; F Pandolfi; P Rossi; D Del Principe; M Fiorilli; I Quinti; F Aiuti
Journal:  J Clin Immunol       Date:  1981-04       Impact factor: 8.317

2.  Improvement of natural killer activity and of T cells after thymopoietin pentapeptide therapy in a patient with severe combined immunodeficiency.

Authors:  M Fiorilli; M C Sirianni; F Pandolfi; I Quinti; U Tosti; F Aiuti; G Goldstein
Journal:  Clin Exp Immunol       Date:  1981-08       Impact factor: 4.330

Review 3.  Thymopentin and splenopentin as immunomodulators. Current status.

Authors:  V K Singh; S Biswas; K B Mathur; W Haq; S K Garg; S S Agarwal
Journal:  Immunol Res       Date:  1998       Impact factor: 2.829
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.